TCV Trust & Wealth Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

TCV Trust & Wealth Management’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,875	Closed	-$12K	–	177
2015 Q1	$12K	Hold	1,875	–	–	﹤0.01%	180
2014 Q4	$12K	Hold	1,875	–	–	﹤0.01%	172
2014 Q3	$19K	Sell	1,875 -1,429	-43%	-$15.3K	﹤0.01%	168
2014 Q2	$37K	Hold	3,304	–	–	0.01%	172
2014 Q1	$40K	Hold	3,304	–	–	0.01%	166
2013 Q4	$42K	Hold	3,304	–	–	0.01%	167
2013 Q3	$55K	Hold	3,304	–	–	0.01%	155
2013 Q2	$50K	Buy	+3,304	New	+$50.2K	0.01%	152

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return

TCV Trust & Wealth Management's LXRX Position: Q2 2015 in Review

TCV Trust & Wealth Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 1,875 shares — an estimated $12K sold.

TCV Trust & Wealth Management first reported a position in LXRX in Q2 2013 and held it in 8 quarters. The position peaked at $55K in Q3 2013. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

TCV Trust & Wealth Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
TCV Trust & Wealth Management sold 1,875 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $12K.
TCV Trust & Wealth Management first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 8 quarters.
TCV Trust & Wealth Management's Lexicon Pharmaceuticals position peaked at $55K in Q3 2013.
94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on TCV Trust & Wealth Management's 13F filing for Q2 2015, filed 23 Jul 2015.